Several studies indicated that cell cycle regulatory gene CDKN2A is hypermethylated in colon cancer cells [42], and decitabine-induced cell proliferation inhibition may result from the release of methylation silencing of the CDKN2A gene [43]. Here, CDKN2A is linked to malignant colon neoplasm.